HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paulo Roberto B Evora Selected Research

Vasoplegia

10/2022Indigo Carmine Hemodynamic Studies to Treat Vasoplegia Induced by Compound 48/80 in a Swine Model of Anaphylaxis.
1/2021After Thirty Years, We Still Cannot Understand Why Methylene Blue is not a Reference to Treat Vasoplegic Syndrome in Cardiac Surgery.
5/2012Guanylate cyclase inhibition by methylene blue as an option in the treatment of vasoplegia after a severe burn. A medical hypothesis.
10/2009Endothelium dysfunction classification: why is it still an open discussion?
12/2006Is methylene blue of benefit in treating adult patients who develop catecholamine-resistant vasoplegic syndrome during cardiac surgery?
3/2004Methylene blue as drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paulo Roberto B Evora Research Topics

Disease

6Vasoplegia
10/2022 - 03/2004
6Anaphylaxis (Anaphylactic Shock)
10/2022 - 09/2002
3Wounds and Injuries (Trauma)
09/2021 - 07/2015
2Burns
09/2021 - 05/2012
2Shock
01/2021 - 09/2002
2Hemorrhage
07/2015 - 06/2007
2Inflammation (Inflammations)
05/2014 - 12/2013
2Hypotension (Low Blood Pressure)
04/2013 - 09/2002
2Ischemia
09/2007 - 01/2005
1Necrosis
09/2021
1COVID-19
01/2020
1False Aneurysm (Pseudoaneurysm)
01/2020
1Neoplasms (Cancer)
01/2018
1Neoplasm Metastasis (Metastasis)
01/2018
1Seizures (Absence Seizure)
01/2018
1Melanoma (Melanoma, Malignant)
05/2015
1Peripheral Arterial Disease
05/2014
1Hyperplasia
05/2014
1Fibrosis (Cirrhosis)
01/2014
1Hypertension (High Blood Pressure)
12/2013
1Pulmonary Hypertension
12/2013
1Myocardial Infarction
01/2013
1Cardiovascular Diseases (Cardiovascular Disease)
07/2011
1Thrombosis (Thrombus)
10/2009
1Spasm (Spasms)
10/2009
1Endocarditis
06/2007
1Starvation
07/2006
1Reperfusion Injury
01/2005
1Hypersensitivity (Allergy)
12/2004
1Inguinal Hernia (Direct Inguinal Hernia)
12/2004

Drug/Important Bio-Agent (IBA)

12Methylene Blue (Methylthioninium Chloride)FDA Link
09/2021 - 09/2002
4Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2021 - 01/2005
3CatecholaminesIBA
05/2012 - 03/2004
3Pharmaceutical PreparationsIBA
03/2008 - 03/2004
2p-Methoxy-N-methylphenethylamineIBA
10/2022 - 03/2008
2AntioxidantsIBA
09/2021 - 12/2013
2Protamines (Protamine Sulfate)FDA Link
05/2016 - 09/2002
1Indigo Carmine (Indigo Blue)IBA
10/2022
1MetalsIBA
09/2021
1NitritesIBA
09/2021
1NitratesIBA
09/2021
1Malondialdehyde (Propanedial)IBA
09/2021
1Hemostatics (Antihemorrhagics)IBA
07/2015
1Matrix Metalloproteinases (MMPs)IBA
05/2014
1Biomarkers (Surrogate Marker)IBA
12/2013
1Vitamin EFDA LinkGeneric
12/2013
1Complement System Proteins (Complement)IBA
01/2013
1C-Reactive ProteinIBA
01/2013
1AminesIBA
05/2012
1Soluble Guanylyl CyclaseIBA
05/2012
1Guanylate Cyclase (Guanylyl Cyclase)IBA
05/2012
1Cardiovascular AgentsIBA
07/2011
1O-methyltyramineIBA
03/2008
1Formaldehyde (Formol)FDA Link
03/2008
1Aprotinin (Trasylol)FDA Link
06/2007
1Saline SolutionIBA
07/2006
1Sodium Fluoride (Ossin)FDA Link
01/2005
1Adenosine Diphosphate (ADP)IBA
01/2005
1Acetylcholine (Acetylcholine Chloride)FDA Link
01/2005
1GTP-Binding Proteins (G-Protein)IBA
01/2005
1Histamine (Histamine Dihydrochloride)FDA Link
12/2004
1Anesthetics (Anesthetic Agents)IBA
12/2004

Therapy/Procedure

2Cardiopulmonary Bypass (Heart-Lung Bypass)
01/2018 - 03/2004
2Resuscitation
07/2015 - 05/2012
1Intradermal Injections
09/2021
1Sutures (Suture)
01/2020
1Drug Therapy (Chemotherapy)
01/2018
1Metastasectomy
05/2015
1Stents
05/2014
1Liver Transplantation
01/2014
1Prostheses and Implants (Prosthesis)
06/2007
1Anesthesia
12/2004
1Therapeutics
12/2004
1Spinal Anesthesia
12/2004